ReviewFrontiers in medicine2017
Innovative Approaches to Increase Access to Medicines in Developing Countries.
Review in Frontiers in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Global, regional and national availability of essential medicines for children, 2009-2020: a systematic review and meta-analysis.BMC public health · 2023Pooled it
- Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review.Globalization and health · 2019Pooled it
- The COVID-19 vaccine procurement and supply chain in the Democratic Republic of Congo.Frontiers in health services · 2025Article
- Health System Responsiveness of Rural Health Units in the Cagayan Valley Region: A Cross-sectional Study.Acta medica Philippina · 2025Article
- Health commodities logistics management information system performance at public health facilities of Amhara region, Ethiopia.Frontiers in public health · 2025Article
- Logistics Management Information System (LMIS) for Health Commodities at Public Health Facilities in Amhara National Regional State of Ethiopia: A Data Quality Evaluation Survey.Journal of multidisciplinary healthcare · 2025Article
- Vaccine Logistics Management Information System at Public Health Facilities in Amhara Region, Ethiopia: A Performance Evaluation.Healthcare informatics research · 2024Article
- Clinical characteristics, diagnosis, treatment and outcomes of patients living with HIV and co-infected with tuberculosis and histoplasmosis: a 5-y retrospective case series.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2024Observational
- Market Transparency in Medicine Pricing: Pathways to Fair Pricing.PharmacoEconomics · 2024Article
- Treatment of highly virulent mammarenavirus infections-status quo and future directions.Expert opinion on drug discovery · 2024Review
- Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council.BMC health services research · 2024Article
- Availability of essential medicines during the COVID-19 pandemic: A qualitative study examining experiences and level of preparedness in Kenya.PLOS global public health · 2024Article
- A Pharmacoeconomic Outlook of the Biological Drugs Marketed in India: A Cost Variance Analysis.Cureus · 2023Article
- How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.Frontiers in public health · 2023Article
- Changes in launch delay and availability of pharmaceuticals in 30 European markets over the past two decades.BMC health services research · 2022Article
- Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.BMC health services research · 2022Article
- Stakeholders' Perspectives Regarding Supply Chain System of Pharmaceuticals and Vaccines in Pakistan: A Qualitative Study.Healthcare (Basel, Switzerland) · 2022Article
- Trends and Challenges in Access to Essential Medicines in Ethiopia and the Contributions of Local Pharmaceutical Production.Ethiopian journal of health sciences · 2022Review
- Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars.Pharmaceutics · 2022Review
- TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.Pharmaceutics · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Access to essential medicines is problematic for one third of all persons worldwide. The price of many medicines (i.e., drugs, vaccines, and diagnostics) is unaffordable to the majority of the population in need, especially in least-developed countries, but also increasingly in middle-income countries. Several innovative approaches, based on partnerships, intellectual property, and pricing, are used to stimulate innovation, promote healthcare delivery, and reduce global health disparities. No single approach suffices, and therefore stakeholders need to further engage in partnerships promoting knowledge and technology transfer in assuring essential medicines to be manufactured, authorized, and distributed in low- and middle-income countries (LMICs) in an effort of making them available at affordable and acceptable conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.